Advisor Group Holdings, Inc. Athersys, Inc Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$0.18 - $0.86 $1,671 - $7,984	9,284 Added 6.32%	156,139 $41,000
Q1 2022 May 04, 2022	BUY	$0.6 - $1.06 $12,837 - $22,679	21,396 Added 17.05%	146,855 $88,000
Q3 2021 Nov 05, 2021	BUY	$1.33 - $1.77 $293 - $391	221 Added 0.18%	125,459 $167,000
Q2 2021 Aug 02, 2021	BUY	$1.41 - $1.94 $14,476 - $19,917	10,267 Added 8.93%	125,238 $180,000
Q1 2021 May 13, 2021	BUY	$1.61 - $2.77 $33,075 - $56,906	20,544 Added 21.76%	114,971 $207,000
Q4 2020 Feb 10, 2021	BUY	$1.55 - $2.24 $14,182 - $20,496	9,150 Added 10.73%	94,427 $165,000
Q3 2020 Nov 12, 2020	BUY	$1.91 - $3.08 $8,117 - $13,090	4,250 Added 5.25%	85,277 $166,000
Q2 2020 Aug 14, 2020	SELL	$1.97 - $3.98 $1,487 - $3,004	-755 Reduced 0.92%	81,027 $224,000
Q1 2020 May 18, 2020	BUY	$1.17 - $3.0 $95,684 - $245,346	81,782 New	81,782 $245,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.